Table 1.
Individuala | Ethnic Origin | Nucleotide Mutationb | Deduced Protein Alteration | Exon or Intron (Zygosity, Segregation) | Amino Acid Evolutionary Conservation | PolyPhen-2 (HumVar) | MutationTaster | Parental Consanguinity | Clinical Diagnosis | Skeletal Features | Renal Disease (ESRD) | Other Clinical Features |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NPH2218 | Hungarian | c.432delA | p.Lys144Asnfs∗15 | 6 (het, p) | - | - | - | no | ATD, JBTS | TD, SS, SLB | NPHP (6 years) | RD, LF, OMA, CVH, ID, obesity |
c.4161G>Ac | p.Arg1387Serfs∗7 | 38 (het, m) | - | - | - | |||||||
A3189-21 | Pakistani | c.886C>Td | p.Arg296Trp | 9 (hom) | D. melanogaster | 0.967 | DC | yes | MZSDS | SS | NPHP (9 years) | RD, ID, died at 12 years |
UCL-87 | Turkish | c.1232T>A | p.Ile411Asn | 13 (hom) (het, p/m) | D. melanogaster | 0.890 | DC | yes | ATD | TD, TA, PD (feet) | none (−) | LF, died at 18 months |
UCL-107 | Turkish | c.1232T>A | p.Ile411Asn | 13 (hom) | D. melanogaster | 0.890 | DC | yes | ATD | TD, TA | none (−) | LF, died at 3 months |
NPH2161 | French | c.1390_1395delGATATT | p.Asp464_Ile465 del | 14 (het) | D. melanogaster and D. rerio | - | - | ND | MZSDS | BD | NPHP (34 years) | RD, cholestasis |
c.5179T>Ce | p.Cys1727Arg | 48 (het) | D. rerio | 0.648 | DC | |||||||
B1 | Belgian | c.1671_1672dupAG | p.Val558Glufs∗12 | 16 (het, p) | - | - | - | no | ATD | TD, TA, PSCE, BD, PD | none (−) | RD, ID |
c.5179T>Ce | p.Cys1727Arg | 48 (het, m) | D. rerio | 0.648 | DC | |||||||
SKDP-44.3 | British | c.2158delC | p.Arg720Valfs∗28 | 21 (het, m) | - | - | - | no | ATD | TD, TA, SS, BD | mild structural abnormalities | RD, cholestasis, OMA, ID, obesity |
c.5179T>Ce | p.Cys1727Arg | 48 (het, p) | D. rerio | 0.648 | DC | |||||||
A3215-21 | South American | c.2716C>T | p.Gln906∗ | 25 (het, m) | - | - | - | no | ATD | TD, SS, GV | NPHP (12 years), RTX (13 years) | ID |
c.4607T>C | p.Leu1536Pro | 42 (het, p) | C. reinhardtii | 0.807 | DC | |||||||
F108-21 | German | c.3228+1G>A | 5′ splice site | 29 (het, m) | - | - | - | no | MZSDS | PCSE, BD | NPHP (11 years) | RD, LF, IGT, obesity |
c.4607T>C | p.Leu1536Pro | 42 (het, p) | C. reinhardtii | 0.807 | DC | |||||||
SKDP-165.3 | Singaporean and Malaysian | c.3907C>T | p.Arg1303∗ | 35 (het, p) | - | - | - | no | ATD | TD, TA, PD, SLB | early cystic dysplasia | LF, VSD, hydrocephalus, died by induced abortion |
c.4630C>T | p.Arg1544Cys | 42 (het, m) | D. melanogaster | 0.991 | DC | |||||||
A2052-21 and A2052-22 | Filipino | c.4630C>T | p.Arg1544Cys | 42 (hom) (het, p/m) | D. melanogaster | 0.991 | DC | yes | ATD, MZSDS, JBTS | TD, TA, PCSE, BD | NPHP (2 years), RTX (4 years) | RD, LF, OMA, CVH, ID |
A3037-21 and A3037-22 | European American | c.4925_4928del GAGA | p.Arg1642Lysfs∗32 | 46 (het, p) | - | - | - | no | MZSDS | PCSE, BD | NPHP (20 years) | RD, LF, obesity |
c.5179T>Ce | p.Cys1727Arg | 48 (het, m) | D. rerio | 0.648 | DC |
Abbreviations are as follows: BD, brachydactyly; ESRD, end-stage renal disease; CVH, cerebellar vermis hypoplasia; DC, predicted to be “disease causing”; GV, genu valgum; het, heterozygous; hom, homozygous; ID, intellectual disability; IGT, impaired glucose tolerance; ATD, asphyxiating thoracic dystrophy; JBTS, Joubert syndrome; LF, liver fibrosis; m, maternal; MZSDS, Mainzer-Saldino syndrome; ND, no data; NPHP, nephronophthisis; OMA, ocular motor apraxia; p, paternal; PD, polydactyly; PCSE, phalangeal cone-shaped epiphysis; RD, retinal degeneration; RTX, renal transplantation; SLB, short long bone; SS, short stature; TA, trident acetabulum; TD, thoracic dystrophy (small bell-shaped thorax); and VSD, ventriculoseptal defect.
In sibling cases, clinical information refers to the underlined individual.
cDNA mutations are numbered according to human cDNA RefSeq NM_015662.1 (IFT172); +1 corresponds to the A of the ATG start translation codon.
This variant abrogates the 3′ splice site (Figure S2). It is in 1000 Genomes (its minor allele frequency is not annotated), but not in the National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project Exome Variant Server (EVS).
NHLBI EVS (n = 6,503 control subjects): T/T = 0; T/C = 1; C/C = 6,502.
NHLBI EVS (n = 6,503 control subjects): C/C = 0; C/T = 1; T/T = 6,502.